Ajit S. Gill

2006

In 2006, Ajit S. Gill earned a total compensation of $12.3M as President and Chief Executive Officer at Nektar Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$148,994
Option Awards$8,789,454
Salary$285,371
Stock Awards$1,388,172
Other$1,700,877
Total$12,312,868

Gill received $8.8M in option awards, accounting for 71% of the total pay in 2006.

Gill also received $149K in non-equity incentive plan, $285.4K in salary, $1.4M in stock awards and $1.7M in other compensation.

Rankings

In 2006, Ajit S. Gill's compensation ranked 158th out of 7,022 executives tracked by ExecPay. In other words, Gill earned more than 97.7% of executives.

ClassificationRankingPercentile
All
158
out of 7,022
98th
Division
Manufacturing
37
out of 2,413
99th
Major group
Chemicals And Allied Products
10
out of 673
99th
Industry group
Drugs
6
out of 518
99th
Industry
Pharmaceutical Preparations
6
out of 355
98th
Source: SEC filing on April 25, 2007.

Gill's colleagues

We found six more compensation records of executives who worked with Ajit S. Gill at Nektar Therapeutics in 2006.

2006

Robert Chess

Nektar Therapeutics

Chief Executive Officer

2006

Ajay Bansal

Nektar Therapeutics

Chief Financial Officer

2006

John Patton

Nektar Therapeutics

Chief Research Fellow

2006

David Johnston

Nektar Therapeutics

Former Senior Vice President Research and Development

2006

Louis Drapeau

Nektar Therapeutics

Chief Financial Officer

2006

Nevan Elam

Nektar Therapeutics

Senior Vice President and Head of the Pulmonary Business Unit

In-depth

You may also like